The Legal and Ethical Advisory Service
The Royal Pharmaceutical Society's Legal and Ethical Advisory Service provides advice on the Codes of Ethics and the Society's interpretation of medicines legislation. This article, produced within the advisory service, describes the services available
Panel 3: Contacting the Legal and Ethical
Advisory Service
The Legal and Ethical Advisory Service is open between
the hours of 9am and 5pm, Monday to Friday, and can be contacted
by telephone
(020 7572 2308), e-mail (ftp@rpsgb.org),
fax (020 7572 2510) or letter (Legal and Ethical Advisory Service,
FTPLA, Royal Pharmaceutical
Society, 1 Lambeth High Street, London SE1 7JN).
Outside these
hours,
or when lines are engaged, messages may be left to be dealt
with when the advisers become free or when the offices reopen.
Other useful
sources of advice were listed in a recent Law and
Ethics Bulletin (PJ, 3 June, p664). |
The Royal Pharmaceutical Society’s Legal and Ethical Advisory Service
has existed in some form since the early 1960s — albeit referred
to by different titles at different times. Established to deal with written
and telephoned enquiries, it now also provides published guidance in ‘Medicines,
ethics and practice: a guide for pharmacists’, in Law and Ethics
Bulletin items in The Pharmaceutical Journal and in a range of fact sheets
available from its own page in the “Fitness
to practise” section
of the Society’s website.
The advisory service team has recently been expanded from four experienced
pharmacists to five. They are based within the Fitness to Practise and
Legal Affairs Directorate at the Society’s London headquarters,
but they also work closely with other units within the Society — particularly
the Technical Information Service and the Practice and Quality Improvement
Directorate — to ensure that all information given is consistent
with the Society’s guidance and policies.
New team member Daniella Murphy says: “Having recently rejoined
the advisory service I feel that this is an exciting time for pharmacy
with all the new changes to the regulations. I am greatly looking forward
to assisting pharmacists in making the necessary adjustments to comply
with these amendments and advising them when in difficult situations.”
Who is the service aimed at?
The service is aimed mainly at those registered with the Society — pharmacists
and pharmacy technicians — who have queries about legal and ethical
aspects of their work. In addition, other health professions and regulatory
bodies may telephone for advice in relation to the practice of pharmacy.
Enquiries are also received from trading standards officers, police officers,
staff of the Veterinary Medicines Directorate, the Home Office and other
health care regulators, and members of the public.
The service can answer queries about a wide range of subjects, including
topics such as Controlled Drugs, collection and delivery services, and
supplies by pharmacists to midwives or paramedics. Routes of enquiry and types of enquirer
The service is accessible by telephone, letter and e-mail. Most enquiries
are received by telephone, but an increasing number of questions are
raised by e-mail.
The e-mail culture has added the odd problem for the service. Carole
Green, the longest serving member of the current team, says: “Having
worked in the advisory service for some time, I have seen the transition
from queries being mainly telephone calls and letters, to telephone calls
and e-mails. Some pharmacists appear to expect a quicker response by
e-mail and are therefore surprised if they have not received a reply
by the next day. But this is not possible because of the number of e-mails
received and the need to research each query, in liaison with other departments
where necessary.”
Last year the service dealt with more than 14,000 enquiries, of which
86 per cent were made by telephone, 11 per cent by e-mail and 3 per cent
by letter. Half of all the enquiries taken by telephone came from community
pharmacists, with a further 12 per cent from hospital pharmacists and
8 per cent from primary care organisations. Academia and industry were
responsible for a further 2 per cent, and prisons, care homes and pharmacy
technicians each accounted for 1 per cent. Members of the public made
5 per cent of the enquiries. The remaining 20 per cent were from a variety
of other sources, including other health care professions and other health
care regulators. This category also includes queries that were not within
the service’s remit. Types of query received
The enquiries received are many and varied. Those submitted by e-mail
or letter tend to be more complex than telephoned enquiries and may
require extensive research if the question is to be answered fully.
Answers to questions may be found by referring to ‘Medicines, ethics
and practice’, fact sheets, Regulations and Acts of Parliament.
In more obscure queries the answer may be found in an old Act of Parliament.
Some queries combine legislation with best practice guidance and policies,
and it is important that responses are researched thoroughly to ensure
that all aspects of the question are addressed.
Pharmacists often ask for guidance on ethical dilemmas that arise in
the course of their practice. Where possible, enquirers will be advised
on relevant legislation and will be referred to the Code of Ethics or
best practice guidance to allow them to make a decision on the most appropriate
course of action. However, it is up to the individual pharmacist to decide
on the appropriate course of action after considering the information
available because pharmacists must be able to justify their decisions
to their peers and to any person or organisation affected by their actions.
When new legislation is implemented or new guidance is issued, the advisory
service usually receives a number of enquiries. A recent example was
the new Misuse of Drugs Regulations amendments, concerning Controlled
Drugs, that came into force in the middle of November 2005. Many pharmacists
had questions initially, and many still do. Guidance
was produced and
published in The Pharmaceutical Journal (PJ, 12 November
2005, p617). However, it has been found that when pharmacists read information
such
as this they may wish to talk through and clarify their understanding
of the changes when they receive a prescription after the new legislation
has come into effect. The service welcomes the opportunity to assist
pharmacists who require further information. Examples of queries
The advisory service is able to answer most of the questions it receives.
However, it declines to answer some questions because it is more
appropriate for them to be addressed by other information sources. When
it is not
possible to provide advice, every endeavour is made to direct the
enquirer to the appropriate source of assistance. Some examples of questions
that the service has answered recently are given in Panel 1 and examples
of recent queries that could not be answered
appear in Panel 2. A recent Law and Ethics Bulletin gave a list
of contact details for a range of organisations that pharmacists
may find useful when researching queries for which the Society’s
advisory service is not an appropriate source of information (PJ,
3 June, p664).
Panel 1: Some queries answered recently
· How should a pharmacist complete an entry in the Controlled
Drug register with regards to faulty Controlled Drug patches supplied
to a patient?
· When did the handwriting requirements for a CD prescription
end?
· When will pharmacies no longer be able to supply strychnine?
· How should a pharmacist address concerns over a doctor’s
prescribing habit?
· What should be done if a patient has brought illicit substances
into hospital with them?
· Where can training be obtained for medicines use review accreditation?
· How can a member of the public make a complaint about a pharmacist
or a service they received in a pharmacy?
· How can a pharmacist supply stock for use in an out-of-hours
service?
· Which items can be supplied by pharmacists to a midwife?
· Which medicines can be placed in an monitored dosage system container? |
Panel 2: Some recent queries that could
not be answered
· How can a patient
in a care home self medicate?
Referred to the Commission for Social
Care Inspection
· How can a doctor set up a travel
clinic?
Referred to the Medicines and Healthcare products Regulatory
Agency and the General Medical
Council
· Who should investigate the sale of medicines from non-pharmacy
premises on eBay?
Referred to the Medicines and Healthcare products
Regulatory Agency
· How can a person set up a business
to import medicines into the UK?
Referred to the Medicines and Healthcare
products Regulatory
Agency
· How can a nurse transport CDs from
one place to another?
Referred to the Nursing and Midwifery Council
and the Home Office |
Occasionally the service is asked about subjects that do
not fall within the Society’s remit. The service is unable to advise
other health care professionals about what is best practice within their
own sphere
of activity and in these situations the health professional will be directed
to his or her own professional body or appropriate authority for advice.
The advisory service is also asked about the actions of others who are
not involved in health provision. For instance, enquirers often ask about
the legality of sales of general sale list (GSL) medicines from petrol
stations, market stalls and other non-pharmacy locations. Many people
(including pharmacists) are unaware that the Medicines and Healthcare
products Regulatory Agency is responsible for regulation of the supply
of such medicines from non-pharmacy locations — and also the supply
of prescription-only medicines from non-pharmacy locations by methods
such as personal distribution, mail order and the internet. Where a query
falls outside the remit of the advisory service, the enquirer will, wherever
possible, be directed to the appropriate agency.
Regardless of which sector of practice they work in, pharmacists and
registered pharmacy technicians are encouraged to use the advisory service.
There is no charge for contacting the service. Fact sheets
Before contacting the advisory services, enquirers may wish to see
whether their query is answered in one of the fact sheets produced by
the service.
All the fact sheets can be downloaded as PDF files from the Legal
and Ethical Advisory Service page of the Society’s website. There
are currently 13 fact sheets, with two more expected shortly.
The fact sheets are written with a view to providing comprehensive
information about various topics based on new legislation and guidance
as well as
queries received from members. When amendments to current legislation
come into force, the fact sheets are updated to ensure they include accurate
information. This is why the “Controlled Drugs and community pharmacy” and “Controlled
Drugs and hospital pharmacy” fact sheets have been withdrawn temporarily.
The advisory service is awaiting further clarification from the Home
Office and the Department for Environment, Food and Rural Affairs following
the implementation of the new waste regulations and amendments to the
Misuse of Drugs legislation.
Team member Ambrose Paschalides said: “It is important that all
our fact sheets are updated regularly, so that pharmacists have current
information that they can rely on. It is a great responsibility to be
the person who must ensure that a fact sheet accurately reflects any
changes that have been made to legislation. Pharmacists refer to fact
sheets and use the information contained within them to make decisions
on the course of action to take in a particular situation. The information
will often be needed in difficult situations and pharmacists must be
able to trust that the information is accurate, considering the source.
This is the reason why fact sheets may be withdrawn for revision when
legislation changes mean that they would contain out-of-date information.”
The recently added “Employing a locum / working as a locum” fact
sheet (number 13), was written in response to queries from locums and
employers about what was required from them, in addition to the personal
responsibilities contained in the Code of Ethics.
The most recent fact sheet, added in March, is on the sale
of non-medicinal poisons from pharmacies (PJ, 1 April, p402). MEP updates
Each July, ‘Medicines, ethics and practice: a guide for pharmacists’ is
updated. The advisory service is responsible for updating its “legal” content.
This challenging task involves adhering to a deadline while trying to
incorporate last minute changes to legislation. As new legislation comes
into force, the relevant parts of MEP are amended and kept on file to
be included in the list to be sent to the editor. Currently, only the
alphabetical list of medicines for human use is updated more frequently,
because it is also accessible
online.
On some occasions whole sections of the MEP guide may need to be rewritten.
On other occasions just certain parts may require attention, eg, the
advanced electronic signature as part of the prescription only medicines
section.
Recent changes to the Misuse of Drugs Regulations 2001 mean that the
MEP’s handwriting exemptions section, the requirements for Controlled
Drug prescriptions and the Controlled Drugs register section will all
need to be amended for this year’s 30th edition. A section on extended
formulary nurse prescribers and Controlled Drugs will have to be amended,
following changes to the Misuse of Drugs Regulations and the Prescription
Only Medicines (Human Use) Order 1997. Additionally, the section on supply
of Controlled Drugs to misusers will have to be changed to include the
addition of ascorbic acid to the list of drug paraphernalia that specified
persons (including pharmacists) can supply to illicit drug users for
the purpose of administering or preparing Controlled Drugs. In the interim,
a Law and Ethics Bulletin has
been published in The Pharmaceutical
Journal giving guidance on these changes (PJ, 12 November
2005, p617).
Commenting on the updating of the MEP, team member Priya Sejpal says: “Before
I started working here I never fully appreciated how much time it took
for the MEP to be written. The cycle begins towards the end of February
and lasts right up until the beginning of July. It’s a lot of hard
work but great fun at the same time — although I probably wouldn’t
say that by the time we are proof reading the fifth draft!” Law and Ethics Bulletins
Most of the Law and Ethics bulletins that appear in The Pharmaceutical
Journal are written by the pharmacist advisers. As with the Controlled
Drug example given above, some of the topics relate to recently enacted
legislation. Others reflect the types of queries being received. On
occasion they may be drafted as a result of one of the Society’s
disciplinary hearings.
Team member Joanne Anokwuru says: “Law and Ethics Bulletins may
advise on recent changes in legislation or serve as reminders to pharmacists
about good practice issues that may have been highlighted by a complaint
to the Society. When writing an LEB, the accuracy and accessibility of
information is essential. They are featured in The Pharmaceutical Journal
to provide guidance to pharmacists. Past LEBs can provide a good learning
tool and resource. Those published since 2001 can be easily accessed
at PJ Online (www.pjonline.com/lawandethics).” |